These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 19340752)

  • 1. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of conventional biomarkers for risk stratification in chronic heart failure.
    Niizeki T; Takeishi Y; Kitahara T; Suzuki S; Sasaki T; Ishino M; Kubota I
    J Cardiol; 2009 Apr; 53(2):179-87. PubMed ID: 19304120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for chronic heart failure.
    Lainscak M; von Haehling S; Springer J; Anker SD
    Heart Fail Monit; 2007; 5(3):77-82. PubMed ID: 17487296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
    Lainscak M; von Haehling S; Anker SD
    Int J Cardiol; 2009 Mar; 132(3):303-11. PubMed ID: 19144431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Natriuretic peptides in patients with heart failure].
    Horii M; Saito Y
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():84-7. PubMed ID: 15506343
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of b-type natriuretic peptide in heart failure management.
    Newton PJ; Betihavas V; Macdonald P
    Aust Crit Care; 2009 Aug; 22(3):117-23. PubMed ID: 19589695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in heart failure. Does prognostic utility translate to clinical futility?
    Maisel A
    J Am Coll Cardiol; 2007 Sep; 50(11):1061-3. PubMed ID: 17825715
    [No Abstract]   [Full Text] [Related]  

  • 9. Congenital heart disease, exercise capacity and B-type natriuretic peptide.
    Carvalho VO
    Cardiol J; 2009; 16(5):489; author reply 490. PubMed ID: 19753535
    [No Abstract]   [Full Text] [Related]  

  • 10. Natriuretic peptide testing in heart failure.
    Kim HN; Januzzi JL
    Circulation; 2011 May; 123(18):2015-9. PubMed ID: 21555724
    [No Abstract]   [Full Text] [Related]  

  • 11. Natriuretic peptides in heart failure: their role in daily practice.
    Loboz-Grudzień K; Jaroch J
    Cardiol J; 2009; 16(1):1-3. PubMed ID: 19130409
    [No Abstract]   [Full Text] [Related]  

  • 12. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.
    Daniels LB; Maisel A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 14. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosing acute heart failure: the mathematician and the clinician.
    Dickstein K
    J Am Coll Cardiol; 2009 Oct; 54(16):1522-3. PubMed ID: 19815123
    [No Abstract]   [Full Text] [Related]  

  • 16. FPIN's clinical inquiries: brain natriuretic peptide for ruling out heart failure.
    Cullan A; Grover M; Hitchcock K
    Am Fam Physician; 2011 Jun; 83(11):1333-4. PubMed ID: 21661716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
    Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Do we need even more new biomarkers?].
    Schnabel RB; Blankenberg S
    Dtsch Med Wochenschr; 2013 Mar; 138(13):662-4. PubMed ID: 23512370
    [No Abstract]   [Full Text] [Related]  

  • 20. Are multiple biomarker testing strategies ready for prime time in heart failure?
    Lee DS; Tu JV
    Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.